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1Department of Biochemistry and Biophysics, University of Rochester Medical Center, Rochester, New YorkABSTRACT Antimicrobial lipopeptides (AMLPs) are antimicrobial drug candidates that preferentially target microbial mem-
branes. One class of AMLPs, composed of cationic tetrapeptides attached to an acyl chain, have minimal inhibitory concentra-
tions in the micromolar range against a range of bacteria and fungi. Previously, we used coarse-grained molecular dynamics
simulations and free energy methods to study the thermodynamics of their interaction with membranes in their monomeric state.
Here, we extended the study to the biologically relevant micellar state, using, to our knowledge, a novel reaction coordinate
based on hydrophobic contacts. Using umbrella sampling along this reaction coordinate, we identified the critical transition
states when micelles insert into membranes. The results indicate that the binding of these AMLP micelles to membranes is
thermodynamically favorable, but in contrast to the monomeric case, there are significant free energy barriers. The height of
these free energy barriers depends on the membrane composition, suggesting that the AMLPs’ ability to selectively target
bacterial membranes may be as much kinetic as thermodynamic. This mechanism highlights the importance of considering olig-
omeric state in solution as criterion when optimizing peptides or lipopeptides as antibiotic leads.INTRODUCTIONThe pressing need for novel antibiotics against resistant
strains of bacteria and fungi has become a global medical
concern. An emerging class of antimicrobial drug candi-
dates, antimicrobial peptides (AMPs), has been the focus
of significant research on antiresistance antibiotics (1).
Unlike traditional antibiotics that target specific growth or
function processes of the microbes, many AMPs were found
to disrupt the structure and function of their membranes (2).
AMPs’ lipophilicity endows them with a few advantages as
antimicrobial drugs. Membrane composition is relatively
conserved during evolution, which makes AMPs less
vulnerable to evolved resistance than traditional antibiotics.
Moreover, AMPs’ membrane binding mechanism shields
them from several resistance strategies, such as multidrug
efflux transporters (3,4).
However, there are also disadvantages that limit AMPs’
clinical application. One of the major hurdles is that they
are expensive to manufacture, process, and store because
they are much larger and chemically complex than typical
drug molecules (5,6). This is in part because there appears
to be a lower limit to the size of traditional AMPs; they
must be hydrophobic enough to bind membranes stably,
and thus must have a significant number of hydrophobic
side chains to overcome the polarity of the peptide
backbone. Additional residues, often cationic, are usually
required to make the peptides selective for anionic bacte-
ria-like membranes. The result is that most natural AMPsSubmitted April 16, 2015, and accepted for publication July 1, 2015.
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0006-3495/15/08/0750/10are 12–40 amino acids long, far larger than most druglike
molecules.
Another major obstacle to AMPs’ application is the lack
of understanding the relation between their oligomerization
in solution and their biological activity. Some AMP oligo-
mers are associated with improved peptidase resistance
(7,8) and enhanced cell selectivity (7,9–14) compared to
their monomers. While the former can be understood as
the consequence of structural changes upon oligomerization
or exclusion from degrading enzymes’ active sites, the
reason for the latter remains a mystery. Although the micro-
bial membranes are believed to be the major targets of
AMPs, one cannot rule out the possibility that other cell sur-
face structures could affect the membrane activity of AMPs.
In fact, it was surmised that the preassembled AMPs might
be retained by macromolecules on cell surfaces and kept
from interacting with membranes simply because of their
increased sizes compared to monomers (11,14). Unfortu-
nately, the limited resolution from experiments and the
lack of molecular insights make it hard to explain why
this kind of blockage would only occur for certain microbial
species with specific AMPs, as opposed to being a universal
phenomenon. One could attempt to examine the impact of
AMP oligomerization on membrane binding by simply
introducing more hydrophobic amino acids to increase the
propensity to form oligomers, but this approach would
also alter the structure of the individual molecules, and
likely the membrane interaction as well. Alternatively, one
could covalently link the monomers together (14), but this
approach would significantly increase the cost of AMP
manufacturing; moreover, the choice of linkage wouldhttp://dx.doi.org/10.1016/j.bpj.2015.07.011
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state.
All the aforementioned complexities complicate the
efforts to optimize their performance. For example, in
typical virtual screening studies where AMPs’ activity is
modeled based on their primary sequences, the large amount
of training data required to build an accurate model is prac-
tically impossible to obtain for large peptides due to the
limit in generating high-throughput screening arrays, where
the number of array elements scales exponentially with the
peptide length (15). Also, peptides tend to be flexible, with a
broad range of accessible conformations; this can signifi-
cantly complicate the interpretation of mutagenesis data,
as even seemingly simple substitutions can significantly
alter the peptides’ conformation and pose relative to the
membrane. This flexibility also makes AMPs challenging
targets for computer simulation; their structural plasticity
combined with the slow relaxation times for lipid-peptide
interactions make it very hard to acquire adequate statistical
sampling, even using state-of-the-art enhanced sampling
methods (16,17). For these reasons, as well as their suscep-
tibility to protease degradation in vivo and their potential
toxicity to human cells (5), there has been only limited suc-
cess in making AMPs into internal antibiotics (15).
In an attempt to bypass the specific issues of AMPs,
Avrahami and Shai (18,19) devised an alternative approach
to utilize AMPs’ membrane activity by conjugating fatty
acids to short cationic peptides. These small synthetic mol-
ecules, called antimicrobial lipopeptides (AMLPs), mimic
AMPs’ amphipathicity and cationic nature, and have been
shown to be potent antimicrobials with minimal inhibitory
concentrations in the micromolar range. Based on a more
recent design of AMLP scaffold, C16-KXXK, where
‘‘C16-’’ denotes the palmitoyl chain attached to the N-termi-
nus of the tetrapeptide KXXK containing two lysines and
two guest residues X, Makovitzki et al. (20) found several
potent antimicrobials that had insignificant hemolysis. Later
work further showed that similar AMLPs were able to clear
infections in vivo (21). Most notably, C16-KGGK (the bold
letter denotes the D-enantiomer, included to confer resis-
tance to peptidase degradation (22)), the most potent among
these AMLPs, has a micromolar MIC against several
pathogenic microbes, including both bacteria and fungi.
The attachment of the acyl chains to peptides also promoted
their aggregation (23), making these lipopeptides excellent
models for studying oligomerization.
Most of the experimental work on these AMLPs to date
focused on their efficacy on a macro- or mesoscopic scale,
so relatively little is known about their mechanisms at the
level of individual molecules. To better understand AMLPs’
mode of action, our lab has been using a combination of
all-atom and coarse-grained (CG) molecular dynamics
(MD) simulations to examine these lipopeptides’ membrane
activity. While all-atom simulations provide atomic details
about the membrane perturbation caused by AMLPs (24),it is prohibitively expensive to quantitatively measure the
thermodynamics of membrane binding. We thus used a
CG model to examine slow processes such as AMLPs’ bind-
ing to membranes (25,26). The CG model we used, the
MARTINI force field, is designed such that each CG particle
represents four heavy atoms; it generally runs at least two
orders of magnitude faster than an equivalent all-atom
model (27,28) and is able to reproduce experimental results
in many cases (29–34).
Our previous simulations using the MARTINI model
quantified the binding thermodynamics of monomeric
C16-KGGK to membranes (26). Our results indicated that
the acyl chain of these AMLPs dominates their binding
affinity to membranes, while the peptide portion confers
selectivity for anionic membranes (26). However, both ex-
periments (23) and simulations (24,25) suggested that these
AMLPs tend to aggregate into nanostructures at moderate
concentrations; such aggregates are thought to enhance
AMLPs’ solubility and antimicrobial activity and could
contribute to their resistance to degradation. Thus, the focus
of this work is to study the interactions between larger
aggregates (micelles) of AMLPs and membranes.
However, there are technical difficulties regarding the
simulation of amphiphile aggregation. Aggregates of even
moderate size tend to be at least metastable, so obtaining
a well-equilibrated size distribution is very challenging,
requiring either very long simulations or efficient enhanced
sampling algorithms. For example, an analogous process,
vesicle fusion, takes place in milliseconds to hundreds of
microseconds, which is extremely challenging to simulate
using brute-force methods (35), even with a CG force field.
To explore the process of AMLPs binding to membranes by
brute-force means, we would need to consider the transfer of
any AMLP from one aggregate to another as well as from an
aggregate to membrane. These transitions are very slow,
because they require partial exposure of the hydrophobic
tails to water (26).
In this study, we introduce, to our knowledge, a novel
reaction coordinate, the hydrophobic contact number, that
characterizes the aggregation of amphiphiles and their bind-
ing to membranes. Using umbrella sampling along this
reaction coordinate, we calculated the free energy of the
formation of a C16-KGGKmicelle in water and the binding
of this micelle to membranes. Our results show that this
micelle has much higher affinity to the anionic bacterial-
like membrane than the neutral mammalian-like membrane,
consistent with our previous results on the monomeric C16-
KGGK (26). Most surprisingly, these calculations revealed
a significant free energy barrier to micelle membrane entry,
which was absent in the monomeric C16-KGGK case. This
barrier is much higher in the case of the zwitterionic
mammalian-like membrane than the anionic bacterial-like
membrane, which means the binding to the latter is more
favorable not just thermodynamically but kinetically as
well. Our analysis reveals that the mechanisms of micelleBiophysical Journal 109(4) 750–759
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which explains the variation in the barrier. The results
suggest a link between the stability of the lipopeptide mi-
celles and their membrane selectivity and provide biophys-
ical insight into antimicrobial drug optimization based on
AMLPs.MATERIALS AND METHODS
System construction
All systems were modeled using the MARTINI coarse-grained force field,
Vers. 2.2P (36,37). We used two lipid bilayer compositions: a 2:1 mixture
of POPE (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine) and
POPG (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoglycerol), representing
a Gram-negative bacteria-like membrane, and pure POPC (1-palmitoyl-
2-oleoyl-sn-glycero-3-phosphocholine), representing a mammal-like
membrane. Construction of the membrane bilayers was described previ-
ously in Horn et al. (25). Each system contained 480 lipids (240 per
leaflet), and care was taken to ensure both leaflets had the same com-
position. Hydration was modeled using the polarizable MARTINI water
model (36).
The C16-KGGK molecule was constructed by merging the MARTINI
palmitoyl with the MARTINI KGGK peptide. The MARTINI model does
not have sufficient resolution to represent chirality, but this is not a serious
limitation: a four-residue peptide is too short to form secondary structure,
and in any event, experiments show that varying the backbone chirality
has no significant effect on the lipopeptide’s properties (38). For the pur-
poses of the MARTINI model, we treated these peptides as random coil,
and did not apply any secondary structure restraints. A box of water with
randomly scattered C16-KGGKs was equilibrated for several hundred
nanoseconds until the C16-KGGKs aggregated into micelles. We extracted
the largest of these micelles and removed several lipopeptides to produce
a 48-mer; binding a single 48-lipopeptide micelle to either membrane
composition produces a 10:1 lipid/peptide.
For each bilayer composition, we placed the C16-KGGK micelle ~60 A˚
from the bilayer center of mass. The system was then solvated with water,
and sodium and chloride ions were added to reach a concentration of
~100 mM. Extra counterions were added to neutralize the charges on lipids
and lipopeptides. The membrane binding simulations contained a total of
51,300 CG particles, while the simulations of micelle formation in water
contained 12,730 particles.Umbrella sampling
The potentials of mean force (PMF) to bind a C16-KGGKmicelle to a lipid
bilayer were calculated using umbrella sampling and the weighted histo-
gram analysis method (WHAM) (39). The reaction coordinates (RCs) we
used were based on the number of hydrophobic contacts within the micelle
and between the micelle and the membrane; the reasons using these RCs
(in place of more common choices, such as the distance from the membrane
center) are discussed in Section S1.1 in the Supporting Material.
Specifically, the number of contacts between a pair of molecules i and j is
defined as a smooth function of the distance between their centers-of-mass
distance rij,
Sij

rij
 ¼ 1
1þ rij

r0
n (1)
where r0 is the distance at which the contact is exactly 0.5 and n controls
the steepness of the function. The total number of contacts between twogroups of particles A and B is the sum of Sij over all the unique pairs
between A and B:Biophysical Journal 109(4) 750–759CAB ¼
X
i˛A
X
j˛B
Sij: (2)
Note that in the case of A¼ B, we constrained the sum so that is j and any
pair of i and j appears only once in the sum.
To facilitate the computation, we used a neighbor list with a cutoff
distance Rcut to keep track of the pairs involved in Eq. 2. We chose Rcut
so that both Sij(Rcut) and dSij=drijðRcutÞ were sufficiently small (see
Table S1). In all cases, the neighbor list was updated every five steps in
all the simulations.
The restraint potentials in umbrella sampling are of the form
U ¼ k
2

CAB  C0AB
2
; (3)
with C0AB being the reference position of each window.
The details of RC definition, the parameters in Eqs. 1–3, and the numberof sampling windows are summarized in Table S1. Note that in the mem-
brane binding simulations, we purposely chose to only sample a subset of
the range of RCs in Table S1, and the reference positions (C0AB in Eq. 3)
of all the umbrella sampling windows are plotted in Fig. S1. This range
of RCs covers the transformation from the micelle being far away from
the membranes to all lipopeptides in the micelle inserted and spread out
in the upper leaflet.
The structures used to seed the umbrella sampling windows were gener-
ated by steered MD (SMD) simulations, where the equilibrium positions of
the harmonic potential in Eq. 3 were moved from a starting position to an
ending position at constant velocity. Multiple SMD simulations with
different starting and ending positions were used so that the desired range
of the reaction coordinate was covered. Snapshots from the SMD simula-
tions were used to seed the umbrella samplings such that the starting RC
values were as close to the centers of the window as possible.Hamiltonian replica exchange
For the micelle formation simulations, Hamiltonian replica exchange
(HREX) was used to facilitate the convergence of the umbrella sampling.
The umbrella sampling windows were exchanged using a Gibbs sampling
algorithm described in Chodera and Shirts (40). The HREX was attempted
every 500 steps. In principle, we could have used HREX for the micelle-
membrane binding simulations as well, but the very large number of simu-
lation windows used in these calculations (z800) made the procedure
unfeasible with our computational resources.Weighted histogram analysis method
The weighted histogram analysis method (WHAM) (39) was used to
calculate the PMFs from the umbrella sampling data. The dynamic range
of the PMFs in each system we were dealing with in this study was
usually ~200–300 kcal/mol and the number of umbrella sampling windows
was ~600–800. Performing WHAM on such a dataset turned out to be quite
challenging, and common implementations of WHAM (41) failed to com-
plete the calculation due to numerical instability. Moreover, in some cases
the termination condition of WHAM iteration produced unconverged
solutions even in the case of a relatively small tolerance (106). This is
due intrinsically to the slower convergence of WHAM iteration, which
has been discussed before in Zhu and Hummer (42). To tackle these issues,
we implemented an optimized version of WHAM in Cþþ based on the idea
proposed by Zhu and Hummer (42), where the WHAM equations were
solved by maximizing the target likelihood function via the Polak-Ribiere
conjugate gradient method with Brent’s line search (43). A multiple preci-
sion library (44) was used in this implementation to achieve numerical
stability in WHAM.
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formation were calculated using 472 bins and a convergence threshold
of 1010 The PMFs of micelle-membrane binding were calculated using
a 300  300 grid and a convergence threshold of 1010.Minimum free energy paths
From each of the two-dimensional membrane binding PMFs, we used the
string method (46) to calculate the minimal free energy paths (MFEPs) in
the two-dimensional contact space. In all cases, the string was initially con-
structed by 200 images or nodes linearly interpolated between the two
terminal nodes at the minima corresponding to the respective surface-bound
and inserted states. We refer the reader to ‘‘PMFs for Membrane Building’’
and Fig. 2 later in the article for the definition of these states. The forward
Euler method was used to propagate the images with a step size of 0.1 in
both dimensions. Bicubic interpolation was used to evaluate the numerical
gradients at the images at each step. We terminated the calculation if the
mean Cartesian distance of the images between two consecutive steps
was <0.001. In some cases, the string fluctuated around an equilibrium
with a fluctuation of 0.01 and we simply terminated the calculation and
took the final string as our result. Such fluctuation is due to the relatively
coarse grid on which the PMFs were calculated where not all the stationary
points of underlying continuous PMFs were resolved. Also, the interpolated
numerical gradients inevitably introduced some errors. However, we do not
think this would affect any of the conclusions in this study because such
errors are minuscule.Simulation protocol
All simulations were performed using GROMACS, Ver. 4.6.3 (47–49) with
the modification described in Umbrella Sampling. For the general MD
simulation parameters, we used a 20-fs time step, and updated the neighbor
list every five steps. Simulations were performed in isothermo-isobaric
(NPT) ensemble with Nose´-Hoover temperature coupling (50,51) and the
Parrinello-Rahman barostat (52), set to 300 K and 1 bar, respectively. Elec-
trostatics were accounted for using the shift function with a Coulomb cutoff
of 12 A˚. A shift was used for van der Waals as well, with a switch distance
of 9 A˚ and a cutoff of 12 A˚.A
BEach of the micelle formation umbrella sampling simulations was run
for ~500 ns where the first 100 ns were considered equilibration phase,
and were excluded from WHAM and any analysis. This totals to 348 ms
(500 ns/window 696 windows) simulation time. The duration of the equil-
ibration phase was determined by gradually excluding N samples from the
beginning of the simulations when we ran WHAM, where N increased
with a step size of 50 ns.We called the firstN samples the equilibration phase
when increasing N does not change the corresponding PMFs significantly.
The PMFs corresponding to N in the range between 50 and 250 are plotted
in Fig. S11. Most of the membrane binding simulations were run for
~1.3 ms and the windows near the transition states (where there is the most
structural diversity) were extended to ~3.7 ms, where the first 350 ns were
considered equilibration phase and excluded fromWHAMand any analysis.
The total simulation time is 1626.4 ms and 1434.4 ms, in the respective cases
of POPE:POPG and POPCmembrane. The dynamics in theMARTINI force
field is usually faster than an equivalent all-atom force field because the
coarse-graining results in a smoother potential energy surface; other groups
have suggested that simulation times should be multiplied by a factor of 4 to
compensate (30), but because the focus of this work is thermodynamics
rather than kinetics, we believe it is clearer not to do so.RESULTS
PMFs of micelle formation
The potential of mean force (PMF) for 48 C16-KGGK mol-
ecules to aggregate into one micelle is shown in Fig. 1 A.
The PMF has three distinct minima, each corresponding to
a distinct oligomerization state of the lipopeptides. The first
(x z 270) and second minima (x z 345) represent a
mixture of different sizes of oligomers ranging from 10 to
30 lipopeptides; the third minimum (xz 450) corresponds
to a micelle of 48 lipopeptides. The maximum at smallest
RC values (x z 28) corresponds to dispersed lipopeptides
in water. Interestingly, the global minimum is not the
48-mer but most likely the coexistence of a 17- and aFIGURE 1 (A) PMF in kcal/mol (y axis) as a
function of the total number of C16-C16 contacts
(x axis, the same as B) between all unique pairs
of 48 C16-KGGKs. (B) The joint probability in
log10 scale (color box) as a function of the number
of C16-C16 contacts (x axis) and the size of
lipopeptide clusters (y axis). (Two dashed lines)
References to a 32- and a 16-mer, respectively.
To see this figure in color, go online.
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754 Lin and Grossfield31-mer (Fig. 1 B) and the free energy barrier to combining
the 17- and 31-mer into the 48-mer is ~22 kcal/mol; the
48-mer is metastable by ~9.0 kcal/mol. At least some of
this free energy difference is due to the finite size of the
simulation cell; each additional lipopeptide added to the
micelle removes a lipopeptide from the surrounding bath,
artificially increasing the entropic penalty to add the next
one (see ‘‘C16-KGGK Oligomerization Is Likely To Be
Polydisperse’’ for more details).
Fig. 1 B shows the joint probability of observing a specific
lipopeptide micelle/cluster size and the number of hydro-
phobic contacts formed among the lipopeptides. It is clear
that a mixture of lipopeptide micelles/clusters of different
sizes dominate the global PMF minima (x z 345), indi-
cating that the C16-KGGK solution is polydisperse (see
C16-KGGK Oligomerization Is Likely To Be Polydisperse
for more discussion). It is worth noting that a trace amount
of monomers coexists with bigger oligomers near the global
minimum as well as the transition to the third minimum
(rightmost well in Fig. 1 A). 10  50  90  130  170  210
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FIGURE 2 The PMFs in kcal/mol (color-scale) of binding a C16-KGGK
micelle to either a POPE:POPG (A) or POPC (B) lipid membrane as a func-
tion of the number of C16-C16 (x axis) and C16-lipid tail (y axis) contacts
(bottom panel). The MFEP was plotted (black line) on the respective PMF.
(A1–A3 and B1–B3) States along the minimum free energy path; 1 refers to
the surface-associated state, 2 to the transition state, and 3 to the fully in-
serted state. (Labels and lines) Locations of these states on the PMF (bottom
panel). POPC lipids (cyan), POPE (pink), POPG (blue), C16 (red), and
KGGK (green). To see this figure in color, go online.PMFs for membrane binding
The PMFs for a 48-C16-KGGK micelle binding to a mem-
brane contacts are shown in Fig. 2, A and B. These PMFs are
characterized by a surface-bound (Fig. 2, A1 and B1) state
and an inserted state (Fig. 2, A3 and B3). These two states
are bridged by various transition states (Fig. 2, A2 and B2)
residing along a set of saddle points on the PMFs. For refer-
ence, we called the case where the micelle is far away from
the membrane, corresponding to the upper-right corner of
Fig. 2, A and B, the free state.
When the micelle binds to the POPE:POPG membrane,
the surface-bound state (Fig. 2 A1) is a local minimum of
the PMF (Fig. 2 A), stabilized by the favorable interactions
between the POPG phosphates and the lysine side chains in
the lipopeptides. In contrast, the equivalent state in the
POPC case (Fig. 2 B1) is not metastable (Fig. 2 B); it ap-
pears that lysine-phosphate interactions are not strong
enough to stabilize surface binding in the absence of anionic
headgroups. However, we still refer this state to the surface-
bound state for the sake of comparison. The inserted states
in both lipids are structurally similar, with the C16 tails of
lipopeptides embedded in the membrane hydrophobic
core, leaving the KGGK peptides in the membrane-solvent
interface.
Aside from the difference in shape, the two PMFs are also
distinct from each other in their scales, as shown by the up-
per limits of the color-bars in Fig. 2, A and B. This is shown
more clearly in the PMFs along the MFEPs in Fig. 3, mak-
ing it evident that binding to the anionic POPE:POPG mem-
brane is far more favorable than binding to POPC.
Moreover, the binding mechanism and transition states
differ significantly depending on the membrane composi-
tion. When binding to the POPE:POPG membrane, the lip-Biophysical Journal 109(4) 750–759opeptide micelle gets flattened, with the C16 tails stretching
out from inside the micelle to the POPE:POPG membrane;
this distortion is compensated by strong electrostatic inter-
actions between the lipid phosphates (particularly for PG
lipids) and the lysine sidechains. By contrast, the micelle
does not tend to stably interact with the surface of the
POPC membrane; instead, the lipopeptides are transferred
into the POPC membrane one at a time, while the micelle
bounces off the surface. The one-at-a-time mechanism is
visible in the series of local minima around the labeled
transition state in Fig. 2 B, with each local minimum repre-
senting a different fraction of lipopeptides transferred from
the micelle to the POPC membrane. We will discuss the
implications for the mechanism in ‘‘Molecular Basis for
AMLPs’ Cooperative Binding to Bacterial Membranes’’.MFEPs of membrane binding
The MFEPs of the C16-KGGK micelle binding to mem-
branes and the PMF values along the paths are shown in
Figs. 2, A and B, and 3, respectively. The MFEP to bind
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FIGURE 3 PMFs in kcal/mol (y axis) along the MFEP (x axis) as
shown in Fig. 2, A and B, of binding a C16-KGGK micelle to either the
POPE:POPG (solid line) or POPC (dashed line) lipid membrane. (Inset,
the POPE:POPG curve) Transition free energy barrier is ~1.3 kcal/mol.
The barrier in the POPC case is ~79 kcal/mol (labeled by arrows). Note
that the path parameters (x axis) of binding to the two different membranes
are not comparable, because the number of contacts formed in the bound
state varies with membrane composition (see Fig. S4). To see this figure
in color, go online.
Lipopeptide Micelle Thermodynamics 755to the POPE:POPG membrane goes from the surface-bound
state to the inserted state with a relatively small transition
barrier of 1.3 kcal/mol. In contrast, the MFEP to bind to
the POPC membrane encompasses the surface-bound and
inserted state, the former of which is part of the transition
ensemble. The barrier to making the transition is both
very high and broad and peaks at ~79 kcal/mol. The loca-
tions of the two MFEPs in the two-dimensional contact
space are put together in Fig. S4 for comparison.DISCUSSION
Using free energy calculations and coarse-grained mole-
cular dynamics simulations, we are trying to address the
following questions regarding the oligomerization of C16-
KGGK and the oligomers’ interaction with membranes:
1) what is the equilibrium distribution of different C16-
KGGK oligomers, and 2) does oligomerization alter the
binding affinity of C16-KGGK to membranes?C16-KGGK oligomerization is likely to be
polydisperse
As shown in Fig. 1, the most likely oligomerization state for
48 C16-KGGK molecules is the formation of a 17- and a
31-mer, with monomers present only occasionally. This
configuration is more favorable than the 48-mer micelle
(second minimum) byz9.0 kcal/mol. However, this result
is altered by the finite size of the simulation cell; as the
micelle forms, the concentration of free lipopeptides drops,which causes the calculation to underestimate the stability
of larger aggregates. We propose a simple analytical correc-
tion for this issue, discussed in Section S3 in the Supporting
Material. When reasonable values for the volumes of
the system and individual molecules are plugged in, the
correction lowers the free energy of the larger aggregate
byz24 kcal/mol relative to the 17-mer/31-mer mix. How-
ever, given the significant uncertainties in the correction,
we are only able to conclude that both minima are likely
thermodynamically accessible. Moreover, these simulations
are too small to completely represent mesoscopic structures
such as fibrils that were observed experimentally in the
case of a similar AMLP (23). Although the precise relative
stabilities of different-sized aggregates may be altered by
the finite size of the calculation, the umbrella sampling
results clearly suggest that the C16-KGGK is most likely
polydisperse in solution.
To test the effects of system size on the distribution of
oligomers, we also ran three independent simulations of
480 C16-KGGK molecules at the same concentration as
in the umbrella sampling ones. The simulations were started
from either dispersed monomeric lipopeptides, 48-mers, or
a mix of 17- and 31-mers; see Section S4 in the Supporting
Material for more details. The size distribution functions of
the C16-KGGK oligomers from these simulations, shown in
Fig. S6, show that the two systems starting from the two
oligomeric states stayed around their respective minima
throughout the simulations, while the one starting from
monomers resulted in a mixture of oligomers with sizes
ranging from 10 to 38 lipopeptides. This demonstrates that
the free energy minima calculated from the umbrella sam-
pling (Fig. 1) are at least metastable, regardless of system
size. The population of larger aggregates remains low
even in the bigger simulations, and even when they occur,
they are not stable. Rather, in these trajectories the large
aggregates really just the result of two smaller aggregates
momentarily colliding, without actually fusing. This could
be a kinetic artifact: medium-sized aggregates do a reason-
able job of hiding the acyl chains from solvent, so fusing
them requires the same kinds of concerted opening events
required for membrane insertion, with significant barriers.
Thus, we conclude that 1) the medium-sized aggregates
are at least metastable at the concentration studied, 2) larger
aggregates are either less favorable thermodynamically
or form on much longer timescales, and 3) a solution of
C16-KGGK is likely to feature a broad range of aggregate
sizes.Micelles greatly enhance membrane selectivity
Given the broad distribution of oligomer sizes (Figs. 1 and
S6), it is not immediately obvious which oligomeric state
is most relevant to the membrane activity seen experimen-
tally. In this study, we chose the 48-mer C16-KGGKmicelle
and a lipopeptide/lipid of 1 :10 as our model systemBiophysical Journal 109(4) 750–759
756 Lin and Grossfieldbecause the expected peptide/lipid in the membrane-bound
state of many antimicrobial peptides with micromolar min-
imal inhibitory concentrations (53) is roughly around this
value.
The umbrella sampling results for the 48-mer C16-KGGK
micelle binding to membranes show that the micellar state
has strong thermodynamic selectivity for anionic mem-
branes; the thermodynamic binding affinity for the model
bacterial membrane is much higher than that for themamma-
lian one, yielding a DDGbinding (DGbacterial DGmammalian¼
246.7 – 19.3) z 227.4 kcal/mol (Fig. 2). Indeed, on a per-
lipopeptide basis, binding to the model mammalian
membrane is z0.40 kcal/mol, less the kBT, while
binding to the model bacterial membrane is favorable
byz5.14 kcal/mol per molecule. This value is much smaller
than the onewe hadmeasured previously (26) for the isolated
lipopeptides using the same model, where binding to the
anionic membranewas favorable by14.5 kcal/mol; the dif-
ference reflects the stability of the micelle relative to the
monomer in solution.
However, the effect of micellization on binding kinetics
is even more striking. Where individual C16-KGGK mole-
cules bind without barrier to both PC and PE:PG membranes
(26), micelles experience distinct barriers that depend on
the membrane composition. The barrier to entering a
POPE:POPG bilayer is relatively small (1.3 kcal/mol),
particularly in contrast to the barrier to enter a zwitterionic
POPC bilayer (79 kcal/mol). The difference in barrier height
is 77.7 kcal/mol, suggesting a difference in binding rates
of 1056.
This result helps explain the function of similar lipo-
peptides in vivo, where host membranes will generally
be more abundant than bacterial ones. Barrierless binding
suggests that isolated lipopeptides will tend to bind
strongly (DG < 10 kcal/mol) to whatever membrane
they encounter first, making it hard to understand how
the lipopeptides ever reached their bacterial targets.
These results suggest a novel mechanism for selectivity:
binding to host mammalian membranes will be slow
and inefficient as long as the lipopeptides are micellized
in solution, while binding to the bacterial surface will
still be efficient. To our knowledge, this favorable aspect
of AMLP oligomerization has not been discussed previ-
ously in either the experimental or computational
literature.Molecular basis for AMLPs’ cooperative binding
to bacterial membranes
The cooperative binding of C16-KGGK micelles to the
membrane is important for its kinetic selectivity. Because
this mechanism has not been explored previously, it is worth
examining the molecular-level details of the process, in
hopes that we can use the insights to guide rational oligo-
merization-based optimization.Biophysical Journal 109(4) 750–759To quantify to structural changes during C16-KGGK’s
membrane binding, we measured the orientation of the
lipopeptide’ acyl chains, the size of the lipopeptide
micelle/aggregation, the hydration of the lipopeptides, and
the lateral radial distribution functions of different lipids
in different stages of this process. The details of this analysis
and the results are presented in Sections S5.2, S5.3, S5.4,
and S5.5 in the Supporting Material. As described in
Sections S5.2 and S5.5 in the Supporting Material, the
C16-KGGK micelle initially bound to the bacterial mem-
brane via a surface-bound state stabilized by electrostatic
interactions between the peptide side chains and the mem-
brane. These electrostatic interactions were also evident in
previous brute-force simulations done by our group (25),
as well as the umbrella sampling simulations of monomers
binding to membranes (26); these interactions reduce the
free energy barrier to binding bacterial membranes relative
to zwitterionic ones. This can be understood from two per-
spectives, as follows.
First, the long-range electrostatics draw the micelle
toward the membrane, effectively letting it fall downhill
toward the bound state; there is no equivalent interaction
with zwitterionic membranes. It is worth noting that these
calculations were performed with 100 mM salt, and that
this effect would be stronger still in pure water. More inter-
estingly, the micelle altered the lateral structure of the mem-
brane, concentrating the POPG lipids even when the micelle
is relatively far away from the membrane (Fig. S10 A1).
This suggests that lipopeptides’ direct contact with mem-
branes is not a necessary condition to induce lipid demixing.
This suggests that lipopeptide micelles could possibly alter
bilayer structure in a way deleterious to cell health even if
other components of the microbe’s cell surface, such as
the lipopolysaccharides, prevented full binding and
insertion.
Second, when the micelle associated with the membrane
surface, it recruited POPG lipids to stabilize the surface-
bound state. The second step is particularly important in
order to lower the transition barrier to insertion, because
the favorable interactions compensate for the unfavorable
exposure of lipopeptide acyl chains to water required for
insertion (Fig. 2 A2). This demixing of anionic lipids has
been proposed as a separate, pore-independent mechanism
for AMP function (54–56).
With the mammalian membrane, there were no favorable
long-range interactions to draw the micelle to the membrane
surface, so the lipopeptides were instead transferred individ-
ually from the micelle into the membrane while the micelle
remained more or less undistorted in solution; this situation
continued until the micelle became too small to effectively
hide the remaining acyl chains, at which point the remaining
AMLPs were transferred simultaneously into the mem-
brane. This is the origin of the large barrier to insertion
seen in Fig. 2 B2. This can also be seen from the progression
of size distribution of lipopeptide clusters where the
Lipopeptide Micelle Thermodynamics 757diminishing oligomers lingered much longer in the bacterial
membrane case than the mammalian membrane case, as is
evident by the high-end orange curves shown in Fig. S8
A2 compared to those in Fig. S8 B2. What’s more, because
the intermediate-size micelles are metastable in water as
discussed in Section S4.1 in the Supporting Material, the
gradual insertion into the mammalian membrane case
gave rise to a more rugged free energy landscape, especially
around the transition peaks (Figs. 2 B and 3). It is worth
mentioning here that even in case of the bacterial mem-
brane, the lipopeptides could be transferred individually
from the micelle into the membrane during the transition
state but much less significantly so compared to the
mammalian case (see Section S5.2 in the Supporting Mate-
rial). This partial insertion is due to the metastability of the
whole 48-mer micelle as discussed in Section S4.1 in the
Supporting Material as well as the presence of the anionic
membrane, which absorbed the inserted monomers and sta-
bilized the degraded micelle via favorable electrostatic
interactions.
As mentioned above, there was a turning point in the
mammalian membrane case where the micelle became
small enough such that its insertion into the membrane
became cooperative (compare Fig. S7, B1 and B2). The
system arrived at a critical point where the barrier to trans-
ferring one more lipopeptide into the membrane balanced-
out that of pushing the entire oligomer into the membrane;
at this point, the rest of the lipopeptides went into the mem-
brane together. The size of this intermediate micelle was
somewhere between a 20- and a 30-mer, which was around
the equilibrium sizes expected in solution (see Figs. 1 and
S6 and Section S4.1 in the Supporting Material). This raises
a very important question regarding the membrane selec-
tivity of AMLPs: if such intermediate micelles are well
populated as compared to larger ones, the AMLP’s binding
to the mammalian membrane via these intermediate mi-
celles could become comparably fast as to the bacterial
membrane. If so, one could imagine rationally optimizing
the oligomerization state in order to improve selectivity
and reduce side effects from damaging host membranes.
However, doing so would require us to consider the surface
structures of different cell types as they might interact with
micelles of a specific range of sizes.CONCLUSIONS
In this study, we used coarse-grained MD simulations of an
antimicrobial lipopeptide to quantify its free energy of
oligomerization in solution, as well as the free energy of a
typical oligomer’s binding to two lipid bilayer com-
positions, chosen to mimic bacterial and mammalian
membranes. Our results indicated that this lipopeptide,
C16-KGGK, is polydisperse in solution, with an equilib-
rium of oligomers of various sizes. While a previous simu-
lation study showed that the monomer binds to anymembrane rapidly and with high affinity (26), this work
showed that the oligomer’s binding to membranes needed
to overcome a significant free energy barrier that varies
with membrane composition. The result is enhanced ther-
modynamic and kinetic selectivity for bacterial versus
mammalian model membranes.
This study suggests a possible new variable to consider
when rationally optimizing membrane-active peptidic
drugs: controlling the oligomeric state in solution will
vary the mechanism of binding and thus the binding kinetics
in ways not readily predictable by considering the monomer
alone. Given the other practical benefits to oligomeriza-
tion—better solubility, reduced vulnerability to proteolysis,
etc.—this insight may help lead to better antibiotics based
on AMPs.SUPPORTING MATERIAL
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